drugset / Trial / NCT04648969
Prolonged Pulsatile Kisspeptin Administration in Hypogonadotropic Hypogonadism
NaSingle-groupOpen-labelTreatment
Summary
The goal of this study is to develop novel treatments for patients with a condition called hypogonadotropic hypogonadism (HH) through the use of exogenous kisspeptin.
Timeline
- Start
- 2019-05-03
- Primary completion
- 2025-08-31
- Completion
- 2025-08-31
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | kisspeptin 112-121 | Peptide | — | Intravenous |
| Background | Gonadorelin | Protein / enzyme biologic | — | Intravenous |